The evaluation of pancreas β-cell autoantibodies in non-diabetic COVID-19 patients

OBJECTIVE: This study aims to evaluate potential pancreas endocrine damage due to SARS-CoV-2 by measuring β-cell autoantibodies in COVID-19 patients. SUBJECTS AND METHODS: Between June and July 2020, 95 inpatients with a positive COVID-19 test result after polymerase-chain-reaction (PCR) and who met...

Descripción completa

Detalles Bibliográficos
Autores principales: Kayhan, Sanem, Hepsen, Sema, Kalkisim, Hatice Kozan, Sendur, Ibrahim Nahit, Altay, Fatma Aybala, Yalcindag, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Endocrinologia e Metabologia 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10697637/
https://www.ncbi.nlm.nih.gov/pubmed/35657130
http://dx.doi.org/10.20945/2359-3997000000498

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10697637/
https://www.ncbi.nlm.nih.gov/pubmed/35657130
http://dx.doi.org/10.20945/2359-3997000000498

Ejemplares similares